Post-Stroke Spasticity: Clinical Trials

1 trial for Post-Stroke Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Post-Stroke Spasticity: new trials by email Literature Review of Post-Stroke Spasticity trials Research Report on Post-Stroke Spasticity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)
Administration of BMS-986368, Placebo - Post-Stroke Spasticity
Phase 2RecruitingAlberto Esquenazi422026-09-022026-10-01

Narrower conditions

Muscle Spasticity (1)  ·  Nervous System Diseases (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Muscle Hypertonia (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Sponsors

Alberto Esquenazi (1)

Countries

United States (1)

Top investigators

Alberto Esquenazi, MD (1)